• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷和利多卡因(Adenocaine)心脏保存液的 8 小时冷静态储存:走向治疗性停搏。

Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation.

机构信息

Heart Research Laboratory, Department of Physiology and Pharmacology, James Cook University, Townsville, Queensland, Australia.

出版信息

J Thorac Cardiovasc Surg. 2011 Dec;142(6):1552-61. doi: 10.1016/j.jtcvs.2011.05.023. Epub 2011 Jul 13.

DOI:10.1016/j.jtcvs.2011.05.023
PMID:21742347
Abstract

OBJECTIVE

Most cardiac preservation solutions provide safe cold ischemic storage times for 4 to 5 hours. Our aim was to investigate the effects of 8 hours of cold static storage (4°C) using 2 normokalemic, polarizing adenosine-lidocaine (Adenocaine; Hibernation Therapeutics Global Ltd, Kilquade, Ireland) solutions and to compare their functional recovery with hearts preserved in gold standard histidine-tryptophan-ketoglutarate (Custodiol-HTK; Essential Pharma, Newtown, Pa) and Celsior (Genzyme, Cambridge, Mass) solutions.

METHODS

Male Sprague-Dawley rats (350-450 g) were randomly assigned to 1 of 4 groups (n = 8): (1) adenosine-lidocaine cardioplegia with low Ca(2+)/high Mg(2+); (2) 2× adenosine-lidocaine cardioplegia, low Ca(2+)/high Mg(2+), melatonin, and insulin (2× adenosine, lidocaine, melatonin, and insulin); (3) histidine-tryptophan-ketoglutarate solution; or (4) Celsior. Hearts were perfused in working mode, arrested (37°C), removed, stored for 8 hours at 4°C, reattached in Langendorff mode and rewarmed for 5 minutes (37°C), and switched to working mode for 60 minutes. Myocardial oxygen consumption, effluent lactates, and troponin T levels were measured.

RESULTS

Hearts preserved for 8 hours in adenosine-lidocaine and 2× adenosine, lidocaine, melatonin, and insulin returned 50% and 76% of aortic flow and 70% and 86% of coronary flow, respectively, at 60 minutes of reperfusion. In contrast, Custodiol-HTK and Celsior hearts returned 2% and 17% of aortic flow and 11% and 48% of coronary flow, respectively, at 60 minutes of reperfusion. Hearts preserved in adenosine-lidocaine and 2× adenosine, lidocaine, melatonin, and insulin returned 90% and 100% of developed pressures and 101% and 104% of heart rate, respectively. Hearts preserved in histidine-tryptophan-ketoglutarate failed to increase systolic pressure greater than 14 mm Hg (11% baseline) and diastolic pressure greater than 10 mm Hg (17% baseline), and recovered only 16% of heart rate. Hearts preserved in Celsior developed 70% of baseline systolic pressures and 86% recovery of heart rate. At 5 minutes of rewarming after cold storage, the myocardial oxygen consumption for hearts preserved in adenosine-lidocaine, 2× adenosine, lidocaine, melatonin, and insulin, Custodiol-HTK, and Celsior was 23.0 ± 5, 20 ± 4, 15 ± 1, and 10 ± 2 μmol O(2)/min/g dry wt, respectively, with corresponding lactate outputs of 1.8 ± 0.8, 1.5 ± 0.7, 2.6 ± 0.7, and 3.2 ± 1.4 μmol lactate/min/g dry weight. Troponin T was not detected in the coronary effluent of adenosine-lidocaine or 2× adenosine, lidocaine, melatonin, and insulin hearts, whereas Custodiol-HTK and Celsior hearts had troponin T levels of 0.08 and 0.24 μg/mL, respectively.

CONCLUSIONS

We report a 78% return of cardiac output, 90% to 100% return of developed pressures, and 101% to 104% return of heart rate after 8 hours of cold static storage using normokalemic, adenosine, lidocaine, melatonin, and insulin preservation solution in the isolated rat heart compared with 55% cardiac output with polarizing adenosine-lidocaine cardioplegia alone, 4% cardiac output with Custodiol-HTK, and 25% cardiac output in Celsior preservation solutions.

摘要

目的

大多数心脏保存液在 4 至 5 小时的冷缺血保存时间内提供安全保障。我们的目的是研究使用 2 种低钾、极化的腺苷-利多卡因(Adenocaine;Hibernation Therapeutics Global Ltd,Kilquade,爱尔兰)溶液进行 8 小时冷静态保存(4°C)的效果,并将其与使用金标准组氨酸-色氨酸-酮戊二酸(Custodiol-HTK;Essential Pharma,Newtown,Pa)和 Celsior(Genzyme,Cambridge,Mass)溶液保存的心脏进行比较,观察其功能恢复情况。

方法

雄性 Sprague-Dawley 大鼠(350-450g)随机分为 4 组(n=8):(1)低钾/高镁(2)2×腺苷-利多卡因心脏停搏液,低钾/高镁,褪黑素,胰岛素(2×腺苷、利多卡因、褪黑素、胰岛素);(3)组氨酸-色氨酸-酮戊二酸溶液;或(4)Celsior。心脏在工作模式下灌注,停搏(37°C),取出,在 4°C 下保存 8 小时,重新连接在 Langendorff 模式下复温 5 分钟(37°C),然后切换到工作模式 60 分钟。测量心肌耗氧量、流出液中乳酸盐水平和肌钙蛋白 T 水平。

结果

在 8 小时的腺苷-利多卡因和 2×腺苷、利多卡因、褪黑素和胰岛素保存液中保存的心脏,在再灌注 60 分钟时,主动脉流量分别恢复了 50%和 76%,冠状动脉流量分别恢复了 70%和 86%。相比之下,Custodiol-HTK 和 Celsior 心脏在再灌注 60 分钟时,主动脉流量分别恢复了 2%和 17%,冠状动脉流量分别恢复了 11%和 48%。在 8 小时的腺苷-利多卡因和 2×腺苷、利多卡因、褪黑素和胰岛素保存液中保存的心脏,收缩压和心率分别恢复到 90%和 100%。在组氨酸-色氨酸-酮戊二酸保存液中保存的心脏,收缩压大于 14mmHg(11%基础值)和舒张压大于 10mmHg(17%基础值)的情况未超过 14mmHg,且心率仅恢复 16%。在 Celsior 保存液中保存的心脏,收缩压恢复到基础值的 70%,心率恢复到 86%。在冷保存后 5 分钟复温时,腺苷-利多卡因、2×腺苷、利多卡因、褪黑素和胰岛素、Custodiol-HTK 和 Celsior 保存液保存的心脏的心肌耗氧量分别为 23.0±5、20±4、15±1 和 10±2μmol O(2)/min/g 干重,相应的乳酸盐输出量分别为 1.8±0.8、1.5±0.7、2.6±0.7 和 3.2±1.4μmol 乳酸盐/min/g 干重。在冠状流出液中未检测到腺苷-利多卡因或 2×腺苷、利多卡因、褪黑素和胰岛素心脏的肌钙蛋白 T,而 Custodiol-HTK 和 Celsior 心脏的肌钙蛋白 T 水平分别为 0.08 和 0.24μg/mL。

结论

与单独使用极化的腺苷-利多卡因心脏停搏液(55%心输出量)、Custodiol-HTK(4%心输出量)和 Celsior 保存液(25%心输出量)相比,我们在分离的大鼠心脏中使用低钾、腺苷、利多卡因、褪黑素和胰岛素保存液进行 8 小时冷静态保存后,观察到心输出量恢复 78%,收缩压和心率恢复 90%至 100%。

相似文献

1
Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation.腺苷和利多卡因(Adenocaine)心脏保存液的 8 小时冷静态储存:走向治疗性停搏。
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1552-61. doi: 10.1016/j.jtcvs.2011.05.023. Epub 2011 Jul 13.
2
Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation.迈向用于原位心脏移植的新型冷温非去极化、正常血钾停搏模式。
J Thorac Cardiovasc Surg. 2009 Jan;137(1):198-207. doi: 10.1016/j.jtcvs.2008.06.031. Epub 2008 Aug 29.
3
Early reperfusion with warm, polarizing adenosine-lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage.温热极化含腺苷-利多卡因心脏停搏液早期再灌流可改善冷静态保存 6 小时后的心功能恢复。
J Thorac Cardiovasc Surg. 2011 Apr;141(4):1044-55. doi: 10.1016/j.jtcvs.2010.04.040. Epub 2010 Jul 4.
4
Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.用于移植的哺乳动物心脏的长期低温保存:三种心脏停搏液的比较。
J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):624-35.
5
Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.心脏停搏液灌注及在威斯康星大学溶液和圣托马斯医院溶液中保存后心脏的功能恢复。
J Heart Lung Transplant. 1991 Jul-Aug;10(4):537-46.
6
Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia.HTK 液在大鼠长时间冷缺血心脏中优于 Celsior 的心肌保护作用。
Surgery. 2010 Aug;148(2):463-73. doi: 10.1016/j.surg.2010.04.009. Epub 2010 Jun 2.
7
Improved heart preservation with UW preservation solution.使用UW保存液改善心脏保存效果。
J Heart Transplant. 1988 Nov-Dec;7(6):456-67.
8
A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia.采用赛尔修斯溶液或威斯康星大学溶液进行心脏保存,并比较有无预先给予心脏停搏液的效果的对照研究。
J Heart Lung Transplant. 2006 Feb;25(2):219-25. doi: 10.1016/j.healun.2005.08.009. Epub 2005 Dec 20.
9
Deleterious effect of hypothermia in myocardial protection against cold ischemia: a comparative study in isolated rat hearts.低温在心肌保护免受冷缺血损伤中的有害作用:离体大鼠心脏的比较研究。
Transplant Proc. 2012 Oct;44(8):2326-32. doi: 10.1016/j.transproceed.2012.07.007.
10
Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior.使用UW、HTK和Celsior溶液冷藏后对大鼠肝脏凋亡和坏死性细胞死亡的评估。
Transplantation. 2002 Aug 27;74(4):458-64. doi: 10.1097/00007890-200208270-00005.

引用本文的文献

1
Low Calcium-High Magnesium Krebs-Henseleit Solution Combined with Adenosine and Lidocaine Improved Rat Aortic Function and Structure Following Cold Preservation.低钙高镁 Krebs-Henseleit 溶液联合腺嘌呤核苷和利多卡因改善大鼠主动脉冷保存后的功能和结构。
Medicina (Kaunas). 2024 Aug 9;60(8):1284. doi: 10.3390/medicina60081284.
2
Temperature-Related Effects of Myocardial Protection Strategies in Swine Hearts after Prolonged Warm Ischemia.长时间热缺血后猪心脏心肌保护策略的温度相关效应
Antioxidants (Basel). 2022 Feb 28;11(3):476. doi: 10.3390/antiox11030476.
3
Cardioplegia between Evolution and Revolution: From Depolarized to Polarized Cardiac Arrest in Adult Cardiac Surgery.
心脏停搏在演进与变革之间:从成人心脏手术中的去极化心脏停搏到极化心脏停搏
J Clin Med. 2021 Sep 29;10(19):4485. doi: 10.3390/jcm10194485.
4
Normothermic Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.常温心脏灌注联合褪黑素增强大鼠心脏循环性死亡后供心的心肌保护作用,抑制NLRP3炎性小体介导的细胞焦亡。
Front Cell Dev Biol. 2021 Aug 31;9:733183. doi: 10.3389/fcell.2021.733183. eCollection 2021.
5
A state-of-the-art review of the current role of cardioprotective techniques in cardiac transplantation.一篇关于心脏移植中心肌保护技术当前作用的最新综述。
Interact Cardiovasc Thorac Surg. 2021 May 10;32(5):683-694. doi: 10.1093/icvts/ivaa333.
6
New Approaches to Donor Selection and Preparation in Heart Transplantation.心脏移植中供体选择与准备的新方法
Curr Treat Options Cardiovasc Med. 2021;23(5):28. doi: 10.1007/s11936-021-00906-5. Epub 2021 Mar 23.
7
Transplantation of Hearts Donated after Circulatory Death.循环性死亡后捐献心脏的移植
Front Cardiovasc Med. 2018 Feb 13;5:8. doi: 10.3389/fcvm.2018.00008. eCollection 2018.
8
A protocol to study ex vivo mouse working heart at human-like heart rate.研究在类似于人类心率条件下离体小鼠工作心脏的方案。
J Mol Cell Cardiol. 2018 Jan;114:175-184. doi: 10.1016/j.yjmcc.2017.11.011. Epub 2017 Nov 17.
9
Organ protective mechanisms common to extremes of physiology: a window through hibernation biology.极端生理状态下共有的器官保护机制:透过冬眠生物学的一扇窗
Integr Comp Biol. 2014 Sep;54(3):497-515. doi: 10.1093/icb/icu047. Epub 2014 May 21.
10
Development of cardioplegic solution without potassium: experimental study in rat.无钾心脏停搏液的研制:大鼠实验研究
Rev Bras Cir Cardiovasc. 2013 Oct-Dec;28(4):524-30. doi: 10.5935/1678-9741.20130085.